In clinical practice, patients with both type 2 diabetes and heart failure with preserved ejection fraction (HFpEF) often present with overlapping symptoms and complex care needs. The evolving landscape of cardiometabolic treatment has brought new attention to GLP‑1 HFpEF diabetes management, especially as recent evidence suggests that glucagon-like peptide‑1 receptor …
Read More »Cardiometabolic Risk in Women With Diabetes: Screening and Care Strategies
Did you know that women with diabetes have a significantly higher risk of heart disease compared to men with diabetes? While many of the standard care guidelines apply to all patients, women often face additional, underrecognized threats to their heart and metabolic health. Understanding how sex-specific factors—such as hormonal changes, …
Read More »Cardiorenal-Metabolic Disease in Focus: Applying the CKM Framework in Diabetes Practice
The CKM framework in diabetes care—focusing on cardiovascular, kidney, and metabolic health—is more than a trend. It’s a clinical necessity. The ADA’s 2025 Standards of Care urge clinicians to manage these overlapping risks together, not separately. Why? Because patients with diabetes deserve outcomes that go beyond just A1C. This article …
Read More »Beyond GLP‑1s: Are We Overlooking the Role of SGLT2 Inhibitors and Metformin?
Clinicians and care teams are increasingly focused on GLP‑1 receptor agonists, but SGLT2 inhibitors and metformin in diabetes management remain foundational in achieving comprehensive, evidence‑based outcomes. While GLP‑1 therapies generate headlines for weight loss and glucose control, 2025 guidelines still strongly emphasize the cardioprotective and renoprotective benefits of SGLT2 inhibitors …
Read More »When Diabetes Isn’t the Main Problem: Managing Comorbidities Without Losing Focus
Living with type 2 diabetes often means managing more than just blood glucose. For many patients, conditions like cardiovascular disease, chronic kidney disease, or depression take center stage in their care plan. When diabetes isn’t the main problem, how do you keep glucose control on track without compromising treatment for …
Read More »Heart Disease and Diabetes: What Your Patients Need To Know
Explore the vital link between heart disease and diabetes to empower patients in managing their health with informed strategies and preventive care.
Read More »Diabetes and Cardiovascular Risk: A Review of Lipid-Lowering Agents
Diabetes is a serious disease that affects millions of people worldwide. It is associated with an increased risk of cardiovascular disease and other complications. To reduce this risk, various lipid-lowering agents have been developed to lower cholesterol levels and reduce the risk of cardiovascular disease. This article reviews the current …
Read More »Insulin Omission for Weight Loss in a Female Adolescent Treated With Advanced Hybrid Closed-Loop System
In a recent article published in the journal Diabetes Care, researchers from Israel reported on a case of a female adolescent with type 1 diabetes who was intentionally omitting insulin in an attempt to lose weight. The adolescent was treated with an advanced hybrid closed-loop system (AHCL), which is a …
Read More »Blood Pressure Target in Type 2 Diabetes Mellitus
Abstract The prevalence of diabetes mellitus continues to increase worldwide, and it is a well-established cardiovascular risk factor. Hypertension is also an important cardiovascular risk factor to be controlled and is common among patients with diabetes mellitus. Optimal blood pressure (BP) goals have been the subject of great debate in …
Read More »Bromocriptine-QR Therapy and its Impact on the Pro-inflammatory State of Type 2 Diabetes Subjects in Relation to CVD
Sponsored Content Bromocriptine-QR (Cycloset) “is a sympatholytic dopamine D2 agonist for the treatment of type 2 diabetes that has demonstrated rapid (within 1 year) substantial reductions in adverse cardiovascular events in this population by as yet incompletely delineated mechanisms.” This study investigated the impact of Cycloset on the pro-inflammatory state …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.